Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual...
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Announce the First Patient...
Intensity Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR...
Intensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update PR...
Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads